Product NDC: | 0135-0148 |
Proprietary Name: | TAGAMET |
Non Proprietary Name: | cimetidine |
Active Ingredient(s): | 200 mg/1 & nbsp; cimetidine |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0135-0148 |
Labeler Name: | GlaxoSmithKline Consumer Healthcare LP |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | NDA020238 |
Marketing Category: | NDA |
Start Marketing Date: | 20100319 |
Package NDC: | 0135-0148-05 |
Package Description: | 30 TABLET in 1 BLISTER PACK (0135-0148-05) |
NDC Code | 0135-0148-05 |
Proprietary Name | TAGAMET |
Package Description | 30 TABLET in 1 BLISTER PACK (0135-0148-05) |
Product NDC | 0135-0148 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | cimetidine |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20100319 |
Marketing Category Name | NDA |
Labeler Name | GlaxoSmithKline Consumer Healthcare LP |
Substance Name | CIMETIDINE |
Strength Number | 200 |
Strength Unit | mg/1 |
Pharmaceutical Classes |